We’re proud to lead the US$55M Series B round into Ivo, alongside Costanoa Ventures, Uncork Capital, Fika Ventures, GD1 and Icehouse Venture
From Series A to unicorn: continuing our journey with Gilmour Space
Today we're reflecting on the year that was at Blackbird.
Dr Max Ward (UWA) and Ryan Krueger (Harvard) have cracked the maths that make it possible to design useful and plausible mRNA sequences for vaccines.
.webp)
